Results 51 to 60 of about 9,756 (290)

Intratympanic gentamicin treatment for Ménière's disease: A randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study [PDF]

open access: yes, 2014
Background: Gentamicin is used as a therapeutic agent for Ménière's disease because of its vestibulotoxicity causing chemo-ablation of the vestibular sensory epithelia. Its use has increased in recent years. However, there is still no consensus about the
Bremer, H.G. (Hendrik G.)   +9 more
core   +4 more sources

New possibilities in the treatment of Meniere's disease [PDF]

open access: yesVojnosanitetski Pregled, 2002
The results of the treatment of Meniere's disease by intratympanic instillation of gentamicin in 32 patients over a 24-months period were analyzed. The receded vestibular function was found in 96,8% patients whereas in the remaining 3,2% pronounced ...
Milanović Nada   +3 more
doaj   +1 more source

Idiopathic sudden sensorineural hearing loss: Effectiveness of salvage treatment with low-dose intratympanic dexamethasone

open access: yesJournal of Otology, 2021
Objectives: To evaluate hearing outcome of salvage treatment with intratympanic steroids (ITS) in idiopathic sudden sensorineural hearing loss (ISSNHL) refractory to initial systemic steroid (SS) therapy.
Pedro Salvador   +2 more
doaj   +1 more source

Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma

open access: yesInternational Journal of Molecular Sciences, 2021
The treatment of acute hearing loss is clinically challenging due to the low efficacy of drug delivery into the inner ear. Local intratympanic administration of dexamethasone (D) and insulin-like growth factor 1 (IGF1) has been proposed for treatment ...
Jung-Ah Cho   +5 more
semanticscholar   +1 more source

Longitudinal Results With Intratympanic Dexamethasone in the Treatment of Ménière’s Disease [PDF]

open access: yes, 2008
To assess patient satisfaction with vertigo control using intratympanic (IT) dexamethasone (12 mg/mL) for medically refractory unilateral Meniere's disease. STUDY DESIGN: Retrospective study.
Boleas-Aguirre, M.S. (María Soledad)   +4 more
core   +1 more source

A Case of Binocular Vertical Diplopia after Intratympanic Gentamicin Therapy

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2019
Intratympanic gentamicin therapy is a useful alternative treatment for refractory Meniere's disease and is generally well tolerated. Visual disturbances as side effects of this treatment are rarely reported in the literature.
Giacomo Cioffi   +4 more
doaj   +1 more source

Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss

open access: yesDrug Delivery, 2021
Dexamethasone sodium phosphate (Dex-SP) is the most commonly used drug administered via intratympanic injection for the treatment of acute hearing loss, but its penetration efficiency into the inner ear is very low.
S. Jung   +7 more
semanticscholar   +1 more source

Round window membrane and delivery of biologically active agents into the cochlea [PDF]

open access: yes, 2010
Establishing efficient methods for local administration of drugs to the inner ear has great clinical relevance for the management of inner ear disorders. However, the administration route remains a critical issue.
Saber, Amanj K.
core   +1 more source

Evaluation of Levels of Triamcinolone Acetonide in Human Perilymph and Plasma After Intratympanic Application in Patients Receiving Cochlear Implants

open access: yesJAMA Otolaryngology - Head and Neck Surgery, 2021
This randomized clinical trial compares levels of triamcinolone acetonide in perilymph and plasma after intratympanic injection.
V. Dahm   +8 more
semanticscholar   +1 more source

Dexamethasone does not affect endolymphatic hydrops (EH) in patients with Meniere's disease within 24 h, and intratympanic administration of gadolinium plus dexamethasone simplifies high-quality imaging of EH using a novel protocol of 7 min

open access: yesJournal of Otology, 2022
Background: Intratympanic administration of gadolinium chelate allows for a better visualization of endolymphatic hydrops (EH) using MRI than intravenous injection and was recently further improved to facilitate high-quality imaging of EH in 7 min.
Jing Zou   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy